Swayze Eric's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Feb 13, 2026
- Accession no.
- 0000874015-26-000111
- Filed
- Feb 13, 2026
- Trade date
- Feb 13, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.28M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Swayze EricCIK 0001791058 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Common Stock | SSaleDisposed | −9,435 | $81.56 | −$769,518.6 | 38,312 | Direct | |
| Feb 13, 2026 | Common Stock | SSaleDisposed | −6,207 | $82.07 | −$509,408.49 | 32,105 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.